Press conference on what @WHO-convened mission to investigate the origins of #SARSCoV2 found on their China trip is about to start in Wuhan.
(Was originally supposed to start an hour ago before being pushed back)
@WHO It finally started this minute.
@WHO After a lengthy introduction of the mission and its terms of reference, Liang Wannian, who leads the Chinese team of the joint mission, says he will now begin to talk about the key findings, starting with molecular epidemiology.
@WHO Wannian still running through a lot of background that we all know: Similarity of viruses found in bats and pangolins, susceptibility of cats, genomes linked to Wuhan market being identical to each other...
@WHO Sequence data "also showed that some diversity of viruses was already present in the early phase of the pandemic in Wuhan, suggesting unsampled chains of transmission beyond the Huanan market cluster”, says Wannian.
@WHO ILI data from a hospital in Wuhan and SARI surveillance data from a hospital in Hubei province was reviewed, says Wannian. "The findings indicated that there was no substantial unrecognized circulation of #SARScov2 in Wuhan during the latter part of 2019."
@WHO Wannian runs through other evidence and concludes this part:
"This is our basic judgment: It is not possible on the basis of the current information to determine how #SARSCoV2 was introduced into the Huanan market."
@WHO One key goal was to understand what happened in early December 2019, says @Peterfoodsafety.
"Did we did we change dramatically the picture we had beforehand? I don't think so.
Did we improve our understanding? Did we add details to that story. Absolutely."
@WHO @Peterfoodsafety Team did a “detailed and profound search” for cases that might have been missed, says @Peterfoodsafety. “We did not find evidence of large outbreaks that could be related to cases of #COVID19 prior to December 19 in Wuhan or elsewhere."
@WHO @Peterfoodsafety Picture becoming clearer of Huanan market being just part of the spread of #sarscov2 in Wuhan in December, says @Peterfoodsafety. “It was not just only a cluster outbreak in the Huanan market, but the virus was also circulating outside of the market."
@WHO @Peterfoodsafety It "is a very classical picture of the start of an emerging outbreak, where we start with a few sporadic cases early on in the month of December and then we start to see small outbreaks where the disease starts to spread in clusters” incl. the Huanan market, says @Peterfoodsafety
@WHO @Peterfoodsafety "All the work that has been done on the virus, and trying to identify its origin continue to point towards a natural reservoir of this virus and similar viruses in bat populations”, says @Peterfoodsafety. “But … a direct jump from bats in the city of Wuhan is not very likely."
@WHO @Peterfoodsafety Team evaluated four hypotheses, says @Peterfoodsafety. “We sat down and went through these different hypotheses, one by one, and assessed the likelihood by putting forwards arguments for and arguments against such hypotheses. And then assessing the likelihood of each of them."
@WHO @Peterfoodsafety The 4 hypotheses:
1. direct zoonotic spillover
2. spillover from an intermediary host species that might have allowed virus to adapt more
3. introduction via food chain, for example from frozen products
4. lab-related incident
@WHO @Peterfoodsafety "Our initial findings suggest that the introduction through an intermediary host species is the most likely pathway”, says @Peterfoodsafety. But direct spillover and food chain also need some more investigation.
@WHO @Peterfoodsafety “However, the findings suggest that the laboratory incident hypothesis is extremely unlikely to explain introduction of the virus into the human population”, says @Peterfoodsafety suggests the team will not further follow-up that hypothesis with more studies.
@WHO @Peterfoodsafety Still important to "try to identify earlier cases” to better understand early events, says @Peterfoodsafety. “We would recommend to continue some of the good work that has been initiated in looking for material that can be analyzed, that is still available from that time."
@WHO @Peterfoodsafety “A lot of this material has been already looked at”, says @Peterfoodsafety, but there are more sources left to analyse. "One of them just to give an example is blood samples from blood banks, and not only here in Wuhan and other cities and provinces”, but also in other countries.
@WHO @Peterfoodsafety “We need to conduct more surveys into certain animal species that could be the reservoir or act as a reservoir and of course, including more sampling and more studies of bat populations, not only in China”, says @Peterfoodsafety.
@WHO @Peterfoodsafety More work also needs to be done to understand "the possible role of the cold chain, frozen products in the introduction of the virus over a distance”, says @Peterfoodsafety.
@WHO @Peterfoodsafety "We know that the virus can persist and survive in conditions that are found in these cold and frozen environments”, says @Peterfoodsafety. "But we don't really understand if the virus can then transmit to humans and under which conditions this could happen"
@WHO @Peterfoodsafety #sarscov2 could "have taken a very long, and convoluted path involving also movements across borders, travels etc before arriving in the Huanan market”, says @Peterfoodsafety. “Therefore, it's also very interesting to follow up on every one of these clues” from other places.
@WHO @Peterfoodsafety Q about exact likelihood of different hypotheses.
Only "broad categories: most likely, less likely”, says @MarionKoopmans. May change with new data. "We can take this again and say okay with this new information does our assessment of the different pathways change?"
@WHO @Peterfoodsafety @MarionKoopmans Q: why did you discard the lab hypothesis?
Detailed evaluation in the report, says @Peterfoodsafety. Accidents happen, but are rare, he says. Also “the fact that nowhere previously was this particular virus researched or identified, or known”.
@WHO @Peterfoodsafety @MarionKoopmans Team also looked at the BSL4 lab in Wuhan Institute of Virology and "it was very unlikely that anything could escape from such a place”, says @Peterfoodsafety.
During visit of Wuhan Institute of Virology, team had a "very long, frank, open discussion with the management and the staff of the Institute“, says @Peterfoodsafety. They gave a "very detailed description of their research, both present and past." Minutes will be in report.
@Peterfoodsafety Well, this was a very long press conference considering there was not all that much news. The big take-away is that the origins mission has concluded that lab origin is “extremely unlikely” and that an intermediate host is the most likely scenario.
@Peterfoodsafety The most interesting clue was what @MarionKoopmans explained:
That some animals known (rabbits) or suspected (ferret-badgers, bamboo rats) to be susceptible to #SARSCov2 were at Huanan market and came from farms/traders in regions where bats are known to harbor related viruses.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kai Kupferschmidt

Kai Kupferschmidt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kakape

8 Feb
“It seems increasingly clear that manufacturers will have to adjust to the evolution of the virus, taking into account the latest variants for future shots, including boosters”, says @DrTedros at @WHO presser. “We have to be ready to adapt vaccines so they remain effective."
@DrTedros @WHO "These developments highlight why it's so important to scale up manufacturing and rollout vaccines as quickly as possible and as widely as possible to protect people before they're exposed to new variants”, says @drtedros.
@DrTedros @WHO “We need to do everything we can to reduce circulation of the virus with proven public health measures”, says @DrTedros. "Several countries are succeeding in suppressing transmission including those where new variants are circulating."
Read 30 tweets
4 Feb
I‘m struck that it still hasn’t sunk in how much #b117 may change the course of this pandemic.

The initial shock about it being more transmissible seems to have worn off. But we are barely beginning to see its real-world impact.

A story: sciencemag.org/news/2021/02/d…
And a thread
After #b117 was identified in England and seemed to be taking off there, many people like me started looking at Denmark for clues.
Why Denmark? It sequences a lot! Here is a graph from @ECDC_EU from late December showing EU sequencing (look at B and note that it’s a log-scale):
@ECDC_EU Denmark has actually massively scaled-up its sequencing since then.
@MadsAlbertsen85 and his team, who have basically been doing all the sequencing for the whole country, are now getting close to 70% which is about as much as is possible (30% have low virus concentrations).
Read 15 tweets
3 Feb
COVAX facility just published a forecast of what country will receive how much of what #covid19 vaccine in the first half of this year.
Lots of caveats of course. This is mostly AZ vaccine, which does not have emergency use listing yet, for instance.
gavi.org/sites/default/…
Big picture:
Countries can expect to receive vaccine to cover on average 3,3% of their population in first half of 2021, "enough to protect the most vulnerable groups such as health care workers”.
Here is “A” to give you an idea (SFP are self financing countries)
Most vaccine here is AstraZeneca’s:
240 million doses of AZ vaccine licensed to Serum Institute of India (SII)
96 million doses directly from AZ (this was supposed to be 153 million, but some shipments delayed to Q3)
Read 17 tweets
2 Feb
Interim results from Russia’s #covid19 vaccine Sputnik V are out and looking good.

Vaccine efficacy was 91.6%

And once again an even stronger signal on moderate/severe cases:
20/4902 in placebo group
0/14964 in vaccine group
„The development of the Sputnik V vaccine has been criticised for unseemly haste, corner cutting, and an absence of transparency. But the outcome reported here is clear and the scientific principle of vaccination is demonstrated ...“
thelancet.com/journals/lance…
Authors end that comment in Lancet by pointing that the result „means another vaccine can now join the fight to reduce the incidence of #COVID19“.
Read 4 tweets
2 Feb
First results (yes, really!) on what #b117 + E484K might mean from @GuptaR_lab:
„Introduction of the E484K mutation in a B.1.1.7 background to reflect newly emerging viruses in the UK led to a more substantial loss of neutralizing activity by vaccine-elicited antibodies“
Quick explainer:
The researchers took blood from 23 people vaccinated with Pfizer vaccine and then checked how well it neutralized retroviruses that they had engineered to contain the spike protein of #b117 with or without E484K.
Preprint is here: citiid.cam.ac.uk/wp-content/upl…
Interpretation:
This is roughly what I expected given B.1.351 and P.1 data.
If you‘ve followed my reporting the last weeks you know that it is difficult to know whether/how much a drop in neutralization in the lab will translate into a drop in vaccine efficacy in the real world.
Read 7 tweets
1 Feb
And now for the bad news. *sigh*
It looks like #B117, the more transmissible variant first detected in England, has now picked up the E484K mutation as well. That is the one linked to evading SOME immunity in SAfrica and Brazil.

h/t @_b_meyer
assets.publishing.service.gov.uk/government/upl…
@_b_meyer "Preliminary information suggests more than one acquisition event.”

If this is true, it is one more sign that this mutation is a relatively easy way for the virus to acquire some advantage in populations with some immunity.
I worry that we will see this in many places with B117.
@_b_meyer And as @_b_meyer points out it may very well be that a mutation like N501Y makes it more likely for the virus to acquire this mutation because it almost “needs" it.
(Or as @K_G_Andersen would probably say: Maybe Nelly kinda seeks out the bad guys… )

Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!